Vivo Bio Tech consolidated net profit rises 43.24% in the March 2025 quarter
Vivo Bio Tech Limited, a leading biotechnology and pharmaceutical company, has reported a robust financial performance for the quarter ended March 2025. The company’s consolidated net profit surged by 43.24% year-on-year…
